LifeMap Solutions Acquired by Digital Health Leader Sema4

Acquisition Represents Culmination of LifeMap’s Mission

Posted on 2017-08-11 by gothamcomm in Biotech, Healthcare, Pharmaceuticals // 0 Comments

San Jose, California, 2017-Aug-11 — /EPR Network/ — LifeMap Solutions (“LifeMap”), the digital health pioneer and co-developer of ResearchKit-enabled app Asthma Health, today announced that Sema4, an interdisciplinary health information company led by world-renowned bio-mathematician Eric Schadt, PhD, has acquired rights to some of LifeMap’s assets.

“We are excited to combine LifeMap Solutions’ capabilities with Sema4’s clinical, research and data science expertise as we work toward creating more digital health tools like the successful Asthma Health app,” said Dr. Schadt. “That app launched the largest study of asthma management ever performed and helped patients monitor symptoms and medication usage.”

Sema4 aims to revolutionize clinical diagnostics by combining comprehensive screening and diagnostic testing, predictive modeling, cutting-edge technologies, and open-access data to ultimately transform how diseases are predicted, diagnosed, treated and prevented. To that end, Sema4 will continue to build new digital platforms to engage patients and empower them to take control of their data. Sema4 will also aggregate and analyze the data to better understand diseases and ensure patients benefit the most from their data. It is anticipated that LifeMap’s various assets and expertise will accelerate Sema4 on its mission.

“This acquisition is a perfect fit,” said LifeMap Solutions founder and CEO Corey Bridges. “We are proud of the many partnerships we have forged with industry leaders in relatively short order. The deepest and most significant one, though, has been with Dr. Schadt and his team at Mount Sinai. As founder and CEO of Sema4, Dr. Schadt has led his team into the commercial realm, where we are finally able to fully integrate our efforts. This represents the culmination of our founding mission.”

LifeMap was incorporated in May 2014. In the very next year, it became the only commercial developer asked by Apple to participate in the launch of its ResearchKit platform, garnering worldwide attention for creating engaging, innovative, and data-driven mobile health (mHealth) apps. LifeMap has worked closely with world-class research institutions and commercial organizations such as the Icahn School of Medicine at Mount Sinai, Stanford University School of Medicine, the Mount Sinai – National Jewish Health Respiratory Institute, 23andMe, and Medidata. The company built apps that spanned a wide range of uses, from research-themed Asthma Health and MyHeart Counts, to the chronic-disease managing COPD Navigator, and the patient-services app at Mount Sinai Health System in New York. The company quickly gained a reputation as a world-class mHealth developer for both iOS and Android. Numerous research papers based on LifeMap’s technology have been published in peer-reviewed scientific journals such as Nature Biotechnology and JAMA Cardiology.

Terms of the acquisition were not disclosed.

About LifeMap Solutions, Inc.

LifeMap Solutions develops innovative digital health solutions with world-class medical, research, and commercial institutions. From apps for research and clinical care to EMR-supporting middleware, and an app platform, LifeMap’s products empower users to better understand and manage their health and researchers and care providers to reach and serve larger audiences. LifeMap Solutions is headquartered in San Jose, California. For more information, please visit www.lifemap-solutions.com.

About Sema4

Sema4 is an interdisciplinary health information company that is committed to providing open access to data and creating practical tools that help patients, clinicians, and researchers better predict health trajectories. Formerly the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai, Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class academic research that illuminates new directions, and the pioneering information science that puts all the pieces together. And we are sharing the data so each patient’s journey helps everyone complete the greater picture.

Matched content

Editor’s pick